Work

A phase II clinical trial of the phosphatidylserine targeting antibody, bavituximab, in combination with pembrolizumab in patients with advanced hepatocellular carcinoma.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.4_suppl.tps599

Authors: Muhammad Shaalan Beg, Hao Zhu, David Hsieh, Syed Mohammad Ali Kazmi, Aravind Sanjeevaiah, Amit G. Singal, Radhika Kainthla, Leticia Khosama, Kimberli Crane, Rolf A. Brekken, Adam Charles Yopp

Institutions: The University of Texas Southwestern Medical Center, Alaska Native Medical Center

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3004635486

Cites:

Cited by: 1

Related to: 10